CMS Finalizes Expedited TCET Coverage Pathway

The Centers for Medicare & Medicaid Services (CMS) finalized a new Transitional Coverage for Emerging Technologies (TCET) Pathway to expedite Medicare coverage of some FDA-approved breakthrough products. Under this finalized pathway, eligible US Food and Drug Administration (FDA) designated breakthrough devices that fall within a Medicare benefit category can obtain national coverage for several years…

Read More

MichBio Hosts Inaugural Life Sciences Legislative Academy

MichBio hosted a unique and exclusive event for legislators, a Michigan Life Sciences Legislative Academy, wherein bio-industry leaders gathered to educate elected officials about the life sciences ecosystem in Michigan, its economics, and unique needs of the industry, as well as pressing issues related to serving patients, developing treatments, and improving the quality of life…

Read More

Reflections on 2023

As 2023 ends, we’ve been reflecting on the impact our team made on Michigan’s life sciences industry. While there were certainly challenges along the way, we’re proud of the work done here at MichBio and hope you’ve noticed our efforts to convene, connect, inform, and advocate for the statewide life sciences cluster. Some reflections on…

Read More

New CDC Data: COVID-19 Vaccination Safe for Pregnant People

Original Source CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19. “CDC encourages all pregnant people or people who are thinking about becoming pregnant and those breastfeeding to get vaccinated to protect themselves from COVID-19,” said…

Read More

Philippines Approves GMO ‘Golden Rice’ for Commercial Production

Original Source The Philippines became the world’s first country Friday to approve the commercial production of genetically modified “golden rice” that experts hope will combat childhood blindness and save lives in the developing world. A biosafety permit issued by government regulators paves the way for the rice — enriched with the vitamin A precursor beta-carotene…

Read More

Strata Oncology Completes $90 Million Series C Financing

Original Source Funding will accelerate ongoing development of tissue and blood tests to broaden the reach and impact of precision medicine for patients with cancer  ANN ARBOR, Mich., July 28, 2021 – Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced the completion of a $90 million Series C financing,…

Read More

Stryker sells T/Pump product line to C2Dx

Original Post: https://www.massdevice.com/stryker-sells-t-pump-product-line-to-c2dx/ C2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount. The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain, and muscle strains. It can also be used for skin trauma, burns, contusions,…

Read More